HOME >> BIOLOGY >> NEWS
Whitehead Study Supports Existence Of Ancient RNA World, Helps Provide Insight Into Early Evolution Of Life

For decades, many researchers thought that ribonucleic acid, or RNA, was nothing more than a molecular interpreter that helps translate DNA codes into proteins. But research over the past 15 years, including studies at the Whitehead Institute, has been lending credence to the notion of a so-called "RNA world," an era in early evolution when all life forms were based on RNA.

This view faced a difficulty, however. For RNA-based life to survive, it must have acquired the ability to synthesize its own building blocks, and until now, scientists had not found an RNA molecule with this key characteristic.

In this week's issue of Nature, Drs. David Bartel and Peter Unrau of the Whitehead Institute report that they have found an RNA molecule capable of making a nucleotide building block, providing some of the strongest evidence yet to support the RNA world view. In contemporary metabolism, protein enzymes catalyze this nucleotide-synthesis reaction, which involves the addition of a nucleotide base to a sugar phosphate. For the RNA world scenario to be feasible, scientists had to show that RNA molecules could catalyze this reaction without the help of protein enzymes.

The Bartel lab finding provides this evidence and supports the theory that in early evolution, RNA molecules carried out functions now considered to be the domains of DNA and proteins: like DNA in modern biology, RNA stored the genetic information to reproduce, and like protein, RNA synthesized the molecules needed to reproduce.

These and other findings will ultimately help evolutionary biologists address questions about how life began on earth more than three billion years ago.

Theories about the origins of life have long intrigued scientists and lay people alike. "A fundamental question about the origin of life is what class of molecules gave rise to some of the earliest life forms" says Dr. Bartel.

For years, scientis
'"/>

Contact: Seema Kumar
kumar@wi.mit.edu
(617) 258-6153
Whitehead Institute for Biomedical Research
16-Sep-1998


Page: 1 2 3

Related biology news :

1. Whitehead press seminar 2001: new horizons in the post-genome world
2. Whitehead Institute receives National Science Foundation grant to sequence Neurospora
3. Whitehead press seminar: Beyond the scientific frontier
4. Millennium and the Whitehead Institute identify novel protein important in fat absorption
5. Whitehead Receives $35 Million Grant From National Human Genome Research Institute (NHGRI)
6. Whitehead Receives $7 million NIH Grant To Build High-Speed Sequencing Machines
7. Whitehead Study Establishes Role Of DNA Methylation In The Stability Of DNA, Suggests Possible Role Of Undermethylation In Cancer
8. Study: Emission of smog ingredients from trees is increasing rapidly
9. Study explores gene transfer to modify underlying course of Alzheimers disease
10. Study reveals why eyes in some paintings seem to follow viewers
11. Study by Israeli scientists provides insight on DNA code

Post Your Comments:
(Date:7/28/2014)... About 100 drugs already approved by the U.S. Food ... prevent the growth of certain bacterial pathogens inside human ... Mediterranean spotted fever. The findings, published in mBio ... for Microbiology, demonstrate a new way of identifying non-antibiotic ... , A handful of drugs on the list ...
(Date:7/28/2014)... discovery of two additional coral communities showing signs of damage ... of the 2010 spill in the Gulf of Mexico. The ... professor of biology at Penn State University. A paper describing ... in the Gulf of Mexico will be published during the ... of the journal Proceedings of the National Academy of ...
(Date:7/28/2014)... Norwegian explorer Roald Amundsen reached the South Pole in ... arrived long before any human. , Using data from ... the Antarctic continent, including the South Pole, a group ... (DRI) in Reno, Nevada, created the most accurate and ... southernmost continent. The new record, described in an article ...
Breaking Biology News(10 mins):New route to identify drugs that can fight bacterial infections 2Impact of Deepwater Horizon oil spill on coral is deeper and broader than predicted 2Lead pollution beat explorers to South Pole, persists today 2Lead pollution beat explorers to South Pole, persists today 3
(Date:7/25/2014)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ... and commercialization of a once-daily, oral therapy for the ... financial results for the period ended June 30, 2014. ... Reported cash and cash equivalents totaling $37.4 million on ... 2013.  , Reported a net loss of $3.9 ...
(Date:7/25/2014)... July 25, 2014 At the request ... granted a 60-day extension for the public comment period ... Rule for Model Aircraft established by Congress as part ... The 60-day extension establishes the new deadline for comments ... Department of Transportation/FAA notice published in the Federal Register ...
(Date:7/24/2014)... - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) ... long-term, randomized, active control Phase 3 study of Zerenex ... binder, for the treatment of hyperphosphatemia in patients with ... (PhosphatE binding and iRon delivery with FErric CiTrate in ... of the American Society of Nephrology ( JASN ...
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 ... the Global Supply Chain of the biotech industry. ... SCM Innovation Awards, brought to you by the ... global organization of supply chain management professionals for ... given to stakeholders of the Biotech industry – ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6FAA Grants Comment Extension at the Request of AMA 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3
Cached News: